This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, L. F. Articles by Senger, D. R. Search for Related Content PubMed PubMed Citation Articles by Brown, L. F. Articles by Senger, D. R.

American Journal of Pathology, Vol 145, 610-623, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Osteopontin expression and distribution in human carcinomas

LF Brown, A Papadopoulos-Sergiou, B Berse, EJ Manseau, K Tognazzi, CA Perruzzi, HF Dvorak and DR Senger
Department of Pathology, Beth Israel Hospital, Boston 02215.

Osteopontin (OPN), a secreted adhesive glycoprotein, is significantly overexpressed in a variety of experimental models of malignancy. Moreover, increased levels of OPN have been detected in the blood of patients with metastatic carcinoma. To investigate OPN expression and distribution in human carcinomas directly, we studied a wide variety of common tumors by Northern analysis, in situ hybridization, and immunohistochemistry. All 14 tumors studied by Northern analysis showed very substantial increases in OPN messenger (m)RNA when compared to corresponding normal tissues. Moreover, intense labeling for OPN mRNA was detected in 71 of 76 carcinomas studied by in situ hybridization. In most of the carcinomas studied (colon, stomach, duodenum, pancreas, breast, lung, bladder, prostate, ovary, thyroid, and melanoma), tumor cells did not label detectably for OPN mRNA; however, macrophages intimately associated with tumor cells labeled strongly for the OPN transcript. In carcinomas of the kidney and endometrium, both tumor cells and host macrophages labeled strongly for OPN mRNA. The presence of OPN mRNA in macrophages was particularly pronounced at the edge of tumors (ie, the tumor/stroma interface) and in areas of tumor necrosis. Although in most cases tumor cells did not label detectably for OPN mRNA, both tumor cells and macrophages stained for OPN protein, suggesting that OPN secreted by macrophages may bind to tumor cells, possibly through the glycine-arginine-glycine-aspartate-serine cell binding domain in OPN. Collectively, these data suggest that OPN functions in adhesive interactions at the tumor/host interface and thereby may influence processes such as invasion and metastasis.

This article has been cited by other articles:

				P.-L. Chang, L. Harkins, Y.-H. Hsieh, P. Hicks, K. Sappayatosok, S. Yodsanga, S. Swasdison, A. F. Chambers, C. A. Elmets, and K.-J. Ho Osteopontin Expression in Normal Skin and Non-melanoma Skin Tumors J. Histochem. Cytochem., January 1, 2008; 56(1): 57 - 66. [Abstract] [Full Text] [PDF]

				L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF]

				B.-D. Grigoriu, A. Scherpereel, P. Devos, B. Chahine, M. Letourneux, P. Lebailly, M. Gregoire, H. Porte, M.-C. Copin, and P. Lassalle Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment Clin. Cancer Res., May 15, 2007; 13(10): 2928 - 2935. [Abstract] [Full Text] [PDF]

				L. Packer, S. Pavey, A. Parker, M. Stark, P. Johansson, B. Clarke, P. Pollock, M. Ringner, and N. Hayward Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN Carcinogenesis, September 1, 2006; 27(9): 1778 - 1786. [Abstract] [Full Text] [PDF]

				A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al. Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer Am. J. Pathol., July 1, 2006; 169(1): 233 - 246. [Abstract] [Full Text] [PDF]

				Z. Mi, H. Guo, P. Y. Wai, C. Gao, and P. C. Kuo Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells Carcinogenesis, June 1, 2006; 27(6): 1134 - 1145. [Abstract] [Full Text] [PDF]

				V. H.C. Bramwell, G. S. Doig, A. B. Tuck, S. M. Wilson, K. S. Tonkin, A. Tomiak, F. Perera, T. A. Vandenberg, and A. F. Chambers Serial plasma osteopontin levels have prognostic value in metastatic breast cancer. Clin. Cancer Res., June 1, 2006; 12(11): 3337 - 3343. [Abstract] [Full Text] [PDF]

				T. Jang, T. Savarese, H. P. Low, S. Kim, H. Vogel, D. Lapointe, T. Duong, N. S. Litofsky, J. M. Weimann, A. H. Ross, et al. Osteopontin Expression in Intratumoral Astrocytes Marks Tumor Progression in Gliomas Induced by Prenatal Exposure to N-Ethyl-N-Nitrosourea Am. J. Pathol., May 1, 2006; 168(5): 1676 - 1685. [Abstract] [Full Text] [PDF]

				S. S. Kadkol, A. Y. Lin, V. Barak, I. Kalickman, L. Leach, K. Valyi-Nagy, D. Majumdar, S. Setty, A. J. Maniotis, R. Folberg, et al. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 802 - 806. [Abstract] [Full Text] [PDF]

				S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1192 - 1200. [Abstract] [Full Text] [PDF]

				Z. Hu, D. Lin, J. Yuan, T. Xiao, H. Zhang, W. Sun, N. Han, Y. Ma, X. Di, M. Gao, et al. Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4646 - 4652. [Abstract] [Full Text] [PDF]

				R. Mentor-Marcel, C. A. Lamartiniere, I. A. Eltoum, N. M. Greenberg, and A. Elgavish Dietary Genistein Improves Survival and Reduces Expression of Osteopontin in the Prostate of Transgenic Mice with Prostatic Adenocarcinoma (TRAMP) J. Nutr., May 1, 2005; 135(5): 989 - 995. [Abstract] [Full Text] [PDF]

				W.-C. Huang, Z. Xie, H. Konaka, J. Sodek, H. E. Zhau, and L. W.K. Chung Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway Cancer Res., March 15, 2005; 65(6): 2303 - 2313. [Abstract] [Full Text] [PDF]

				L. W. Fisher, A. Jain, M. Tayback, and N. S. Fedarko Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers Clin. Cancer Res., December 15, 2004; 10(24): 8501 - 8511. [Abstract] [Full Text] [PDF]

				Z. Mi, H. Guo, P. Y. Wai, C. Gao, J. Wei, and P. C. Kuo Differential Osteopontin Expression in Phenotypically Distinct Subclones of Murine Breast Cancer Cells Mediates Metastatic Behavior J. Biol. Chem., November 5, 2004; 279(45): 46659 - 46667. [Abstract] [Full Text] [PDF]

				J. O. Schorge, R. D. Drake, H. Lee, S. J. Skates, R. Rajanbabu, D. S. Miller, J.-H. Kim, D. W. Cramer, R. S. Berkowitz, and S. C. Mok Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer Clin. Cancer Res., May 15, 2004; 10(10): 3474 - 3478. [Abstract] [Full Text] [PDF]

				R. Das, G. H. Mahabeleshwar, and G. C. Kundu Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells J. Biol. Chem., March 19, 2004; 279(12): 11051 - 11064. [Abstract] [Full Text] [PDF]

				J. Koopmann, N. S. Fedarko, A. Jain, A. Maitra, C. Iacobuzio-Donahue, A. Rahman, R. H. Hruban, C. J. Yeo, and M. Goggins Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 487 - 491. [Abstract] [Full Text]

				D. Coppola, M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A. F. Chambers, and T. J. Yeatman Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies Clin. Cancer Res., January 1, 2004; 10(1): 184 - 190. [Abstract] [Full Text] [PDF]

				K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck {beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin Mol. Cancer Res., September 1, 2003; 1(11): 810 - 819. [Abstract] [Full Text] [PDF]

				R. Das, G. H. Mahabeleshwar, and G. C. Kundu Osteopontin Stimulates Cell Motility and Nuclear Factor {kappa}B-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells J. Biol. Chem., August 1, 2003; 278(31): 28593 - 28606. [Abstract] [Full Text] [PDF]

				S. Saika, T. Miyamoto, I. Ishida, Y. Ohnishi, and A. Ooshima Osteopontin: A Component of Matrix in Capsular Opacification and Subcapsular Cataract Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1622 - 1628. [Abstract] [Full Text] [PDF]

				C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398. [Abstract] [Full Text] [PDF]

				Q.-T. Le, P. D. Sutphin, S. Raychaudhuri, S. C. T. Yu, D. J. Terris, H. S. Lin, B. Lum, H. A Pinto, A. C. Koong, and A. J. Giaccia Identification of Osteopontin as a Prognostic Plasma Marker for Head and Neck Squamous Cell Carcinomas Clin. Cancer Res., January 1, 2003; 9(1): 59 - 67. [Abstract] [Full Text] [PDF]

				A. O'Regan, C. Fleming, J. D. Seidman, R. C. Wallach, S. C. Mok, S. J. Skates, R. S. Berkowitz, and D. W. Cramer Osteopontin as a Biomarker for Ovarian Cancer JAMA, June 26, 2002; 287(24): 3208 - 3210. [Full Text] [PDF]

				P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer Cancer Res., June 1, 2002; 62(12): 3417 - 3427. [Abstract] [Full Text] [PDF]

				D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A. F. Chambers, M. Szabo, A. Cantor, D. Coppola, and T. J. Yeatman Osteopontin Identified as Lead Marker of Colon Cancer Progression, Using Pooled Sample Expression Profiling J Natl Cancer Inst, April 3, 2002; 94(7): 513 - 521. [Abstract] [Full Text] [PDF]

				S. R. Rittling, Y. Chen, F. Feng, and Y. Wu Tumor-derived Osteopontin Is Soluble, Not Matrix Associated J. Biol. Chem., March 8, 2002; 277(11): 9175 - 9182. [Abstract] [Full Text] [PDF]

				V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis Clin. Cancer Res., January 1, 2002; 8(1): 61 - 74. [Abstract] [Full Text] [PDF]

				N. S. Fedarko, A. Jain, A. Karadag, M. R. Van Eman, and L. W. Fisher Elevated Serum Bone Sialoprotein and Osteopontin in Colon, Breast, Prostate, and Lung Cancer Clin. Cancer Res., December 1, 2001; 7(12): 4060 - 4066. [Abstract] [Full Text] [PDF]

				E. Medico, A. Gentile, C. L. Celso, T. A. Williams, G. Gambarotta, L. Trusolino, and P. M. Comoglio Osteopontin Is an Autocrine Mediator of Hepatocyte Growth Factor-induced Invasive Growth Cancer Res., August 1, 2001; 61(15): 5861 - 5868. [Abstract] [Full Text] [PDF]

				J. L. Fisher, P. S. Mackie, M. L. Howard, H. Zhou, and P. F. M. Choong The Expression of the Urokinase Plasminogen Activator System in Metastatic Murine Osteosarcoma: An in Vivo Mouse Model Clin. Cancer Res., June 1, 2001; 7(6): 1654 - 1660. [Abstract] [Full Text] [PDF]

				G. J. Nau, G. L. Chupp, J.-F. Emile, E. Jouanguy, J. S. Berman, J.-L. Casanova, and R. A. Young Osteopontin Expression Correlates with Clinical Outcome in Patients with Mycobacterial Infection Am. J. Pathol., July 1, 2000; 157(1): 37 - 42. [Abstract] [Full Text] [PDF]

				I. H. N. Wong, A. T. Chan, and P. J. Johnson Quantitative Analysis of Circulating Tumor Cells in Peripheral Blood of Osteosarcoma Patients Using Osteoblast-specific Messenger RNA Markers: A Pilot Study Clin. Cancer Res., June 1, 2000; 6(6): 2183 - 2188. [Abstract] [Full Text]

				H. Sandhu, W. Dehnen, M. Roller, J. Abel, and K. Unfried mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats Carcinogenesis, May 1, 2000; 21(5): 1023 - 1029. [Abstract] [Full Text] [PDF]

				G. N. Thalmann, R. A. Sikes, R. E. Devoll, J. A. Kiefer, R. Markwalder, I. Klima, C. M. Farach-Carson, U. E. Studer, and L. W. K. Chung Osteopontin: Possible Role in Prostate Cancer Progression Clin. Cancer Res., August 1, 1999; 5(8): 2271 - 2277. [Abstract] [Full Text] [PDF]

				G. J. Nau, P. Guilfoile, G. L. Chupp, J. S. Berman, S. J. Kim, H. Kornfeld, and R. A. Young A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis PNAS, June 10, 1997; 94(12): 6414 - 6419. [Abstract] [Full Text] [PDF]

				Qu-Hong, L. F. Brown, H. F. Dvorak, and A. M. Dvorak Ultrastructural Immunogold Localization of Osteopontin in Human Gastric Mucosa J. Histochem. Cytochem., January 1, 1997; 45(1): 21 - 34. [Abstract] [Full Text] [PDF]

				D.-Q. Zheng, A. S. Woodard, G. Tallini, and L. R. Languino Substrate Specificity of alpha vbeta 3 Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway Activation J. Biol. Chem., August 4, 2000; 275(32): 24565 - 24574. [Abstract] [Full Text] [PDF]

				K. J. Bayless and G. E. Davis Identification of Dual alpha 4beta 1 Integrin Binding Sites within a 38 Amino Acid Domain in the N-terminal Thrombin Fragment of Human Osteopontin J. Biol. Chem., April 13, 2001; 276(16): 13483 - 13489. [Abstract] [Full Text] [PDF]

				F. Yeung, W. K. Law, C.-H. Yeh, J. J. Westendorf, Y. Zhang, R. Wang, C. Kao, and L. W. K. Chung Regulation of Human Osteocalcin Promoter in Hormone-independent Human Prostate Cancer Cells J. Biol. Chem., January 18, 2002; 277(4): 2468 - 2476. [Abstract] [Full Text] [PDF]